Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients

Clinical Transplantation

Volumn 20, Issue 1, 2006, Pages 127-131

  Ditschkowski, Marcus ^a   Elmaagacli, A H ^a   Trenschel, R ^a   Steckel, N K ^a   Koldehoff, M ^a   Beelen, D W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Allogeneic transplantation; Elderly; Stem cell transplantation; Stem cells

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; TREOSULFAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ADVANCED CANCER; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; EARLY CANCER; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; TREATMENT OUTCOME;

AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644801990     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00453.x     Document Type: Article

References (15)

1. Yanada M, Emi N, Naoe T et al. Allogeneic myeloablative transplantation for patients aged 50 years and over. Bone Marrow Transplant 2004: 34: 29.
2. Klingemann H-G, Storb R, Fefer A et al. Bone marrow transplantation in patients aged 45 years and older. Blood 1986: 67: 770.
3. Blume KG, Forman SJ, Nademanee A et al. Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older. J Clin Oncol 1986: 4: 1489.
4. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998: 91: 756.
5. Ottinger HD, Ferencik S, Beelen DW et al. Hematopoietic stem cell transplantation: Contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 2003: 102: 1131.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958: 53: 457.
7. Elmaagacli AH, Peceny R, Steckel N et al. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia. Blood 2003: 101: 446.
8. Khouri IF, Albitar M, Saliba RM et al. Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem transplantation for CD52-positive malignancies: Decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics. Bone Marrow Transplant 2004: 33: 833.
9. De la Camara R, Alonso A, Steegmann JL et al. Allogeneic hematopoietic stem cell transplantation in patients 50 years of age and older. Haematologica 2002: 87: 965.
10. Ottinger H, Beelen DW, Massenkeil G et al. Allotransplantation of haematopoietic stem cells for early stage leukaemia in patients aged 40 years or more: Overall survival improves significantly if a younger unrelated donor is preferred over an older sibling donor. Bone Marrow Transplant 2005: 35: S86.
11. Bertz H, Potthoff K, Finke J. Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. J Clin Oncol 2003: 21: 1480.
12. Shimoni A, Kroger N, Zabelina T et al. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: Older age is no longer a contraindication when using reduced intensity conditioning. Leukemia 2005: 19: 7.
13. Shapira MY, Resnick IB, Bitan M et al. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. Bone Marrow Transplant 2004: 34: 155.
14. Gomez-Nunez M, Martino R, Caballero MD et al. Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: Results from the Spanish multicenter prospective trial. Bone Marrow Transplant 2004: 33: 477.
15. Sorror ML, Maris MB, Storer B et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: Influence of pretransplantation comorbidities. Blood 2004: 104: 961.